BCL2 and metastatic malignant neoplasm in the lymph nodes: A meta-analysis by Silva et al., (2023) even suggests that Bcl-2 overexpression may be associated with poorer lymph node metastasis, overall survival (OS), and disease-free survival (DFS), although these findings should be interpreted with caution because of study variability and potential bias [166].